Top Banner
Cardiovascular Medications PICU Resident Talk Stanford School of Medicine Pediatric Critical Care Medicine June 2014
26

Cardiovascular Medications

Feb 16, 2016

Download

Documents

iolana

Cardiovascular Medications. PICU Resident Talk Stanford School of Medicine Pediatric Critical Care Medicine June 2014. Objectives. Define inotropy , chronotropy , lusitropy , and vasopressor. List the determinants of BP and CO. - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Cardiovascular Medications

Cardiovascular MedicationsPICU Resident Talk

Stanford School of MedicinePediatric Critical Care Medicine

June 2014

Page 2: Cardiovascular Medications

ObjectivesDefine inotropy, chronotropy, lusitropy, and

vasopressor.List the determinants of BP and CO.Describe the receptor/ mechanism of action

of epi, norepi, dopamine, dobutamine, milrinone, phenylephrine, and nitroprusside.

List the major side effects of these medications.

Page 3: Cardiovascular Medications

DefinitionsInotropy—the force of muscle contraction,

most commonly cardiac muscle contractionChronotropy—affecting the heart rateLusitropy—relaxation function of cardiac

muscle and chambersVasopressor—producing a rise in blood

pressure through vasoconstriction

Page 4: Cardiovascular Medications

Definitions Bonus !

DromotropyBathmotropy

Page 5: Cardiovascular Medications

Definitions Bonus !

Dromotropy ~ running; increase AV conduction

Bathmotropy ~ threshold; increase excitability of cardiac cells

Page 6: Cardiovascular Medications

Determinants of Blood Pressure

Page 7: Cardiovascular Medications
Page 8: Cardiovascular Medications

Site of Action

Page 9: Cardiovascular Medications

Heart

Vascular Smooth Muscle

vasoconstriction

ChronotropyInotropy

Adrenoreceptors

vasodilation

Page 10: Cardiovascular Medications

Heart

β1 receptors:

Vascular Smooth Muscle

α1 receptors: vasoconstricti

onChronotropyInotropy

Adrenoreceptors

β 2 receptors: vasodilation

Page 11: Cardiovascular Medications

Heart

Vascular Smooth Muscle

NO & PDE Inhibitors

PDE3 Inhibitor: Vasodilation

NO → guanalyl cyclase:

vasodilation

PDE3 Inhibitor: Chronotropy

Inotropy

Page 12: Cardiovascular Medications
Page 13: Cardiovascular Medications
Page 14: Cardiovascular Medications

PDE Inhibitors

PDE 3 PDE 5

Page 15: Cardiovascular Medications

PDE Inhibitors

PDE 3 PDE 5

Milrinone SildenafilTadalafil

Page 16: Cardiovascular Medications

Milrinone

Increases CO

Diastolic relaxation Minimal increase HR and O2 demand

↓ SVR↓ PVR

T1/2 2-4 hrsFurther ↑ in renal impairment

Page 17: Cardiovascular Medications

The meds to choose from….

Page 18: Cardiovascular Medications

Dose: mcg/kg/min Mechanism /Therapeutic Effects Adverse Effects

Epinephrine

Norepinephrine

Dopamine

Dobutamine

Milrinone

Phenylephrine

Nitroprusside

β1 ↑ HR, ↑ inotropy β2 vasodilatationα1 vasoconstriction ↑ SVR

α1 vasoconstriction ↑ SVRβ1 ↑ HR, ↑ inotropy Min β 2 effects

D1 diuresis, natriuresis, renal vasodilatation, (No proven benefit in preventing AKI or ↓ mortality)

β1 ↑ HR, ↑ inotropy

α1 effects vasoconstriction ↑ SVRβ1 ↑ HR, ↑ inotropy Mild β2, α1 antagonist vasodilation ↓ PVR, SVR

Phosphodiesterase Inhibitor (PDE3 inhibitor):Myocardial : ↑ cAMP ↑contractility + lusiotropyVasculature: ↑ cAMP vasodilatation ↓ SVR/PVRα1 vasoconstriction ↑ SVR

NO activates guanalyl cyclase (in vasc smooth muscle) ↑cGMP vasodilation

Arrhythmia↑myocardial O2 demandIschemic injury due to potent vasoconstriction↑ After load

Arrhythmia↑myocardial O2 demand

Arrhythmia, hypotension↑myocardial O2 demandHypotension, arrhythmia T1/2 ↑ in renal impairment Ischemic injury due to potent vasoconstriction↑ afterloadCyanide toxicity↑ V/Q mismatch

0.01- 1

0.01- 1

< 5

5 -10

>10

5-20

0.25 -1

0.1-5

0.1-4

Page 19: Cardiovascular Medications

Dopamine Dobutamine Epinephrine

DopamineDobutamineEpinephrine

Norepinephrine

Milrinone

Increase SVRHigh dose EpiNorepinephrineHigh dose Dopa (>10)Phenylephrine

Decrease SVRLow dose Epi, NitroprussideMilrinoneDobutamine

Page 20: Cardiovascular Medications

Some interesting studies…Dopamine increases risk of infections - Inhibits anterior pituitary function & so ↓ prolactin, GH,

TSH. 1-3

- Prolactin and growth hormone have immunestimulatory properties.4

- Inhibits lymphocyte proliferation, immunoglobulin synthesis, cytokine production, and promote lymphocyte apoptosis. 5-8

- Chronotropic and inotropic effects increases myocardial oxygen demand, may not be adequately met by coronaries risk of tachycardia and tachy-arrhythmias. 9

- Beta adrenergic properties of dopamine predominate in sepsis10

Page 21: Cardiovascular Medications

Some interesting studies…Septic patients treated with dopamine had a higher incidence of

arrhythmias than those treated with norepinephrine.1

Norepinephrine is a more potent vasopressor than dopamine, with norepinephrine being more effective in reversing the hypotension of septic shock.2

In patients with sepsis, norepinephrine increases blood pressure, as well as cardiac output, renal, splanchnic, cerebral blood flow, and microvascular blood flow while minimally increasing heart rate.1,3,4

By achieving these hemodynamic goals, norepinephrine may be better than dopamine in maintaining organ perfusion.

Page 22: Cardiovascular Medications

We did not talk…Ionized calciumVasopressin Isoproterenol

Page 23: Cardiovascular Medications

Ionized Calcium Central role in maintaining myocardial

contractilityEffects mediated via intracellular

concentration, calcium requirements of the muscle cell, sensitivity of the myofilaments to calcium

Agents that increase intracellular cAMP increase intracellular calcium requirements for contraction, thus encouraging smooth muscle relaxation and vasodilation

Page 24: Cardiovascular Medications

Angiotensin IIHyperosmolarityDecreased atrial receptor firing sympethatic stimulation

Vasopressin

Vasoconstriction

Renal fluid reabsorption

Increased blood pressure

Page 25: Cardiovascular Medications

IsoproterenolSynthetic catacholamine. Non specific beta, no alpha. Causes inotropy, chronotropy, and systemic

and pulmonary vasodilatation. Indications: bradycardia, decreased cardiac

output, bronchospasm (bronchodilator).

Page 26: Cardiovascular Medications

THANK YOU !